document.writeln('- Investigation Reveals More Woes for Rosiglitazone<\/a>
On July 15 \(MedPage Today\) -- a day after the FDA completed two days of hearings on rosiglitazone \(Avandia\) -- a British advisory commission on drugs concluded that the product should be withdrawn from the market, according to an investigation conducted by BMJ.
<\/li>- ESC: Stockholm Take Home Message -- Watch the \'Not\' Warfarins<\/a>
STOCKHOLM \(MedPage Today\) -- An investigational antiplatelet -- ticagrelor \(Brilinta\) -- emerged as a big winner from the five-day long European Society of Cardiology congress, but the buzz here focused instead on a trio of investigational oral anticoagulants -- dabigatran, rivaroxaban, and apixaban.
<\/li>- Increased Cardiac Events Seen With Sibutramine \(CME/CE\)<\/a>
\(MedPage Today\) -- Overweight patients with cardiovascular risks who took the weight-loss drug sibutramine had an increased likelihood of experiencing a cardiac event, a large randomized trial found.
<\/li>- Tight BP Control Flops for Most CKD Patients \(CME/CE, with audio\)<\/a>
\(MedPage Today\) -- Intensive blood pressure control doesn\'t slow progression of chronic kidney disease \(CKD\) in hypertensive patients overall but may help those with baseline proteinuria, according to a randomized trial.
<\/li>- ESC: New Anticoagulants Create Buzz<\/a>
STOCKHOLM \(MedPage Today\) -- After years of waiting for an alternative to warfarin \(Coumadin\), there are now three wending their way through the regulatory process. In this exclusive InFocus video report we review each of these new agents with leading cardiologists.
<\/li>- ESC: EINSTEIN DVT Data Positive for Factor Xa Inhibitor \(CME/CE\)<\/a>
STOCKHOLM \(MedPage Today\) -- An investigational oral anticoagulant appears to be as effective and safe as treatment with enoxaparin \(Lovenox\) plus warfarin \(Coumadin\) to prevent recurrent deep vein thrombosis, researchers reported.
<\/li>- ESC: It\'s Not Butter and It\'s Not Better \(CME/CE, with video\)<\/a>
STOCKHOLM \(MedPage Today\) -- Adding margarine enriched with omega-3 fatty acids as a dietary intervention did not prevent second heart attacks in older men and women at risk for worsening heart disease, researchers said here.
<\/li><\/ul>');
document.writeln('<\/html>');
document.writeln('');